MONTE ROSA THERAPEUTICS INC's ticker is GLUE and the CUSIP is 61225M102. A total of 74 filers reported holding MONTE ROSA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,161,541 | -26.3% | 242,493 | +5.3% | 0.00% | – |
| Q2 2023 | $1,576,993 | -9.8% | 230,218 | +2.6% | 0.00% | -100.0% |
| Q1 2023 | $1,747,967 | +2.3% | 224,386 | -0.0% | 0.00% | 0.0% |
| Q4 2022 | $1,708,323 | -1.9% | 224,484 | +5.3% | 0.00% | 0.0% |
| Q3 2022 | $1,742,000 | +55.0% | 213,215 | +83.4% | 0.00% | – |
| Q2 2022 | $1,124,000 | -36.1% | 116,234 | -7.3% | 0.00% | -100.0% |
| Q1 2022 | $1,759,000 | +1.3% | 125,400 | +47.4% | 0.00% | 0.0% |
| Q4 2021 | $1,737,000 | -2.5% | 85,062 | +6.4% | 0.00% | 0.0% |
| Q3 2021 | $1,782,000 | – | 79,974 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,472,331 | $12,029,000 | 7.99% |
| NEA Management Company, LLC | 7,703,205 | $62,935,000 | 3.14% |
| Cormorant Asset Management, LP | 2,993,717 | $24,459,000 | 1.71% |
| Alphabet Inc. | 1,464,015 | $11,961,000 | 0.61% |
| Avoro Capital Advisors LLC | 3,363,333 | $27,478,000 | 0.51% |
| Casdin Capital, LLC | 510,882 | $4,174,000 | 0.27% |
| RTW INVESTMENTS, LP | 1,214,572 | $9,923,000 | 0.23% |
| Woodline Partners LP | 502,411 | $4,105,000 | 0.06% |
| Virtus Investment Advisers, Inc. | 12,638 | $103,000 | 0.05% |
| CORNERCAP INVESTMENT COUNSEL INC | 28,192 | $230,000 | 0.04% |